BJDX — Bluejay Diagnostics, Inc.
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1704287 ·
Last close
$0.92
Market Cap
$953.0K
52W High
$16.68
52W Low
$0.80
ADV30
2,345,923
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 0 | — | -2,349,124 | -2,324,013 | 11,533,900 | 9,598,916 | 2,119,060 |
| Mar 2026 | 0 | — | -1,938,831 | -1,919,241 | 5,598,603 | 3,684,457 | 1,417,408 |
| Dec 2025 | 0 | — | -1,461,747 | -1,429,812 | 7,119,237 | 5,164,875 | 1,143,948 |
| Sep 2025 | 0 | — | -1,616,947 | -1,597,632 | 4,890,258 | 3,082,268 | 1,197,476 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-6,457,918
Investing CF
$-189,049
Financing CF
$7,215,321
CapEx
$-20,114
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-25.09
As of
2026-08-16
Balance + Analyst (yfinance extras)
Retained Earnings
$-43,436,508
Inventory
—
Receivables
—
ST Investments
—
EBIT TTM
$-6,922,270
Pretax Income TTM
$-6,903,289
Interest Exp TTM
$1,338
Analysts
—
Annual Trend (SEC EDGAR, last 5y)
Revenues vs Net Income (last 5y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 0 | -6,952,972 | -6,848,483 | 7,120,000 | 1,140,000 | 5,975,289 | -6,053,575 |
| Dec 2024 | 0 | -7,169,616 | -7,717,794 | 6,660,000 | 927,924 | 5,729,499 | -7,820,822 |
| Dec 2023 | 0 | -10,311,217 | -9,953,888 | 4,870,000 | 1,973,683 | 2,894,848 | -8,313,870 |
| Dec 2022 | 249,040 | -9,317,776 | -9,296,948 | 13,500,000 | 1,979,992 | 11,541,273 | -7,741,593 |
| Dec 2021 | — | — | — | — | — | — | — |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-0.32
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| PREM | Premier Air Charter Holdings Inc. | $951.3K | $0.03 | — |
| LGMK | LogicMark, Inc. | $971.7K | $1.08 | — |
| ODYY | Odyssey Health, Inc. | $1.01M | $0.01 | — |
| ALUR | ALLURION TECHNOLOGIES, INC. | $1.11M | $1.11 | — |
| NUMD | Nu-Med Plus, Inc. | $1.22M | $0.01 | — |
News headlines (Yahoo Finance, 1h cache)
Bluejay Diagnostics Federal Healthcare Partnership Builds Commercial Pathway Ahead of FDA Clearance
2026-09-08 14:55 · Yahoo
Bluejay Diagnostics Reports Q2 2026 Results; Strengthened Balance Sheet Supports Advancement of Symphony™ IL-6 Toward Regulatory Submission and Commercialization
2026-08-13 10:00 · Yahoo
Bluejay Diagnostics Announces Successful Completion of Enrollment in the SYMON-II Multicenter Clinical Validation Study
2026-07-21 10:30 · Yahoo
Bluejay Diagnostics Announces Closing of Up to $23.7 Million Private Placement Priced At-The-Market Under Nasdaq Rules
2026-06-06 00:13 · Yahoo
Bluejay Diagnostics Announces up to $23.6 Million Private Placement Priced At-the-Market Under Nasdaq Rules
2026-06-02 16:19 · Yahoo
Bluejay Diagnostics and Argonaut Manufacturing Services Announce Strategic Partnership
2026-06-02 10:30 · Yahoo
Bluejay Diagnostics Provides First Quarter 2026 Corporate Update
2026-05-07 20:01 · Yahoo
Bluejay Diagnostics and Lovell Government Services Announce Partnership to Expand Access to U.S. Federal Healthcare Markets
2026-09-08 10:30 · Yahoo
Bluejay Diagnostics, Inc. Announces Completion of 624 Patient Enrollments in SYMON-II Pivotal Clinical Trial
2026-04-07 10:30 · Yahoo
Bluejay Announces Abstract Accepted for Presentation at the 2026 Society of Academic Emergency Medicine (SAEM) Annual Meeting
2026-03-12 10:30 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.